Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
The Lancet. Neurology
|
March 21, 2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study
Niklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Cell Stem Cell
|
June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons
Lucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Acta Neuropathologica Communications
|
February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Nature Aging
|
April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
Nicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology
|
May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Alzheimer'S Research & Therapy
|
April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment
Erica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
The Lancet. Neurology
|
March 21, 2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study
Niklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Cell Stem Cell
|
June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons
Lucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Acta Neuropathologica Communications
|
February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Nature Aging
|
April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
Nicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology
|
May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Alzheimer'S Research & Therapy
|
April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment
Erica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Page
of 6